-
US FDA extends review of Ascendis Pharma’s therapy for children with dwarfism
26 Nov 2025 01:48 GMT
… Drug Administration on Tuesday extended its review of Ascendis Pharma’s therapy … that causes dwarfism, the company said.
The health regulator … to the application, the company said.
Ascendis had … resulting in dwarfism.
Ascendis’ therapy, TransCon CNP, targets a …
-
Hereditary Angioedema Therapeutics Market to Reach USD $15.84 Billion by 2029 at 19.5% CAGR
26 Nov 2025 00:15 GMT
… Attune Pharmaceuticals Inc.
• Adverum Biotechnologies Inc.
• Arrowhead Pharmaceuticals Inc.
• Ionis Pharmaceuticals Inc.
• BioCryst Pharmaceuticals Inc … Therapeutics, an American clinical-stage biotech company, introduced a new Investigational New Drug …
-
<![CDATA[EU Approves Liso-Cel in R/R MCL With ≥ 2 Prior Lines of Systemic Therapy]]>
26 Nov 2025 01:36 GMT
… ; the FDA set a Prescription Drug User Fee Act date of … press release.1 “While frontline therapies have advanced over the years … profile in patients with MCL compared with what has been observed … by U.S. Food and Drug Administration (FDA) in fifth cancer …
-
Mursla Bio partners with big pharma company on precision medicine
25 Nov 2025 23:11 GMT
… pharmaceutical company to use its AI Precision Medicine platform to help with drug … development and ultimately develop companion diagnostics. The collaboration … , monitor treatment and develop companion diagnostics.
BioWorld MedTech Obesity
-
Xraised Exclusive Interview with Dr. Anita Davidson: Creative BioTherapeutics’ Mission to Transform Cancer Therapeutics
25 Nov 2025 23:38 GMT
… emerging biotech company pioneering new cancer therapeutics designed to reverse drug and … to biotech leadership. After witnessing promising cancer therapies—developed … treatment resistance.
Most major pharmaceutical companies avoid this space due …
-
CMS unveils IRA prices for Ozempic, Wegovy and other drugs from second round
26 Nov 2025 00:11 GMT
-
US FDA approves Otsuka's drug for a type of kidney disease
26 Nov 2025 01:28 GMT
… approved Otsuka’s injectable drug to treat patients with … showed on Tuesday.
The drug, branded as Voyxact, was … ’ Fabhalta, Travere Therapeutics’ Filspari and Calliditas Therapeutics’ Tarpeyo. While … months of treatment.
The company hopes this improvement will …
-
<![CDATA[FDA Approves Gene Replacement Therapy Itvisma for Patients With Spinal Muscular Atrophy ]]>
26 Nov 2025 00:01 GMT
… associated with other available therapies for this population.1 … in the Itvisma group compared with the sham … discontinued nusinersen (Spinraza; Ionis Pharmaceuticals) or risdiplam (Evrysdi; Roche … Conclusion
According to the manufacturer';s news release …
-
Canada’s Drug Laws Face Challenge from Founders of Vancouver Compassion Club
26 Nov 2025 01:05 GMT
… co-founders of a compassion club trying to … buy drugs from pharmaceutical companies, unless they first had a company … lined up to sell the drugs … to them.
But Drug …
-
Drug-impaired driver's car flew over top of parked vehicle in New Sudbury
26 Nov 2025 01:46 GMT
… years ago, while impaired by drugs, Krisstarah Jeanveau sped through … 102.80 to the insurance company that repaired the damage … expert later concluded Jeanveau was drug-impaired.
The officers also … them to believe she was drug-impaired.
Advertisement 6
This …